Coffee and tea consumption and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

DOI

    Abhijit Sen, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, 45110 Ioannina, Greece. ktsilidis@gmail.com., GrækenlandNikos Papadimitriou, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, 45110 Ioannina, Greece. ktsilidis@gmail.com., GrækenlandPagona Lagiou, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., USAAurora Perez-Cornago, Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK., StorbritannienRuth C Travis, Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK., StorbritannienTimothy J Key, Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK., StorbritannienNeil Murphy, International Agency for Research on Cancer, Lyon, France., FrankrigMarc Gunter, International Agency for Research on Cancer, Lyon, France., FrankrigHeinz Freisling, International Agency for Research on Cancer, Lyon, France., FrankrigIoanna Tzoulaki, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK., StorbritannienDavid C Muller, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK., StorbritannienAmanda J Cross, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK., StorbritannienDavid S Lopez, Division of Urology, The University of Texas Medical School, Houston, TX., USAManuela Bergmann, Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany., TysklandHeiner Boeing, Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany., TysklandChristina Bamia, Hellenic Health Foundation, Athens, Greece., GrækenlandAnastasia Kotanidou, First Department of Critical Care Medicine and Pulmonary Services, University of Athens Medical School, Evangelismos Hospital, Athens, Greece., GrækenlandAnna Karakatsani, 2nd Pulmonary Medicine Department, School of Medicine, National and Kapodistrian University of Athens, "ATTIKON" University Hospital, Haidari, Greece., GrækenlandAnne Tjønneland, Diet, Genes and Environment Unit, Danish Cancer Society Research Center, Copenhagen, Denmark., DanmarkCecilie Kyrø, Diet, Genes and Environment Unit, Danish Cancer Society Research Center, Copenhagen, Denmark., Danmark
  • Malene Outzen
  • María-Luisa Redondo, Public Health Directorate, Asturias, Spain., SpanienValerie Cayssials, Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., SpanienMaria-Dolores Chirlaque, Department of Epidemiology, Murcia Regional Health Authority, Murcia, Spain; Department of Health and Social Sciences, Universidad de Murcia, Murcia, Spain., SpanienAurelio Barricarte, IdiSNA, Navarra Institute for Health Research, Pamplona, Spain., SpanienMaria-Jose Sánchez, Escuela Andaluza de Salud Pública. Instituto de Investigación Biosanitaria ibs. GRANADA. Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain., SpanienNerea Larrañaga, Public Health Division of Gipuzkoa, Regional Government of the Basque Country, Donostia, Spain., SpanienRosario Tumino, Cancer Registry and Histopathology Unit, "Civic-M.P.Arezzo" Hospital, ASP, Via Dante N° 109, 97100 Ragusa, Italy., ItalienSara Grioni, Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, 1, 20133 Milano, Italy., ItalienDomenico Palli, Cancer Risk Factors and Life-Style Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy., ItalienSaverio Caini, Cancer Risk Factors and Life-Style Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy., ItalienCarlotta Sacerdote, Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy., ItalienBas Bueno-de-Mesquita, Department of Social & Preventive Medicine, Faculty of Medicine, University of Malaya, Pantai Valley, 50603, Kuala Lumpur, Malaysia., MalaysiaTilman Kühn, Division of Cancer Epidemiology, German Cancer Research Center (DKFZ)., TysklandRudolf Kaaks, Division of Cancer Epidemiology, German Cancer Research Center (DKFZ)., TysklandLena Maria Nilsson, Department of Public Health and Clinical Medicine,Nutritional Research, Umeå University,Umeå,Sweden., SverigeRikard Landberg, Department of Biology and Biological Engineering, Chalmers University of Technology, 412 96 Gothenburg, Sweden., SverigePeter Wallström, Nutrition Epidemiology Research Group. Dept. of Clinical Sciences, Lund University, Malmö, Sweden., SverigeIsabel Drake, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden., Sverige
  • Bodil Hammer Bech
  • Kim Overvad
  • Dagfinn Aune, Bjørknes University College, Oslo, Norway., NorgeKay-Tee Khaw, MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, United Kingdom., StorbritannienElio Riboli, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK., StorbritannienDimitrios Trichopoulos, Hellenic Health Foundation, Athens, Greece., GrækenlandAntonia Trichopoulou, Hellenic Health Foundation, Athens, Greece., GrækenlandKonstantinos K Tsilidis, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK., Storbritannien

The epidemiological evidence regarding the association of coffee and tea consumption with prostate cancer risk is inconclusive, and few cohort studies have assessed these associations by disease stage and grade. We examined the associations of coffee (total, caffeinated and decaffeinated) and tea intake with prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition. Among 142,196 men, 7,036 incident prostate cancer cases were diagnosed over 14 years of follow-up. Data on coffee and tea consumption were collected through validated country-specific food questionnaires at baseline. We used Cox proportional hazards regression models to compute hazard ratios (HRs) and 95% confidence intervals (CI). Models were stratified by center and age, and adjusted for anthropometric, lifestyle and dietary factors. Median coffee and tea intake were 375 mL/day and 106 mL/day, respectively, but large variations existed by country. Comparing the highest (median of 855 mL/day) versus lowest (median of 103 mL/day) consumers of coffee and tea (450 mL/day versus 12 mL/day) the HRs were 1.02 (95% CI, 0.94-1.09) and 0.98 (95% CI, 0.90-1.07) for risk of total prostate cancer, and 0.97 (95% CI, 0.79-1.21) and 0.89 (95% CI, 0.70-1.13) for risk of fatal disease, respectively. No evidence of association was seen for consumption of total, caffeinated or decaffeinated coffee or tea and risk of total prostate cancer or cancer by stage, grade or fatality in this large cohort. Further investigations are needed to clarify whether an association exists by different preparations or by concentrations and constituents of these beverages. This article is protected by copyright. All rights reserved.

OriginalsprogEngelsk
TidsskriftInternational Journal of Cancer
Vol/bind144
Tidsskriftsnummer2
Sider (fra-til)240-250
Antal sider11
ISSN0020-7136
DOI
StatusUdgivet - 15 jan. 2019

Se relationer på Aarhus Universitet Citationsformater

ID: 128559047